DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage

Eggel, Alexander; Baumann, Michael J; Amstutz, Patrick; Stadler, Beda M; Vogel, Monique (2009). DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage. Journal of molecular biology, 393(3), pp. 598-607. Amsterdam: Elsevier 10.1016/j.jmb.2009.08.014

Full text not available from this repository. (Request a copy)

The concept of multispecific antibodies is of high therapeutic interest but has failed to produce pharmaceutical products due to the poor biophysical properties of such molecules. Here, we propose an alternative and simple way to generate bispecific binding molecules using designed ankyrin repeat proteins (DARPins). For this purpose, monovalent DARPins with different epitope specificities were selected against the alpha chain of the high-affinity receptor for human immunoglobulin E (IgE) (FcepsilonRIalpha). Two of the isolated binders interfering with IgE binding to the receptor were joined to each other or to themselves via a flexible protein linker. The resulting bivalent and bispecific DARPins were tested for their ability to prevent allergen-induced cell degranulation using rat basophilic leukemia cells stably transfected with human FcepsilonRIalpha. The bispecific DARPin construct was the most potent one, efficiently blocking the IgE-FcepsilonRI interaction and preventing the release of proinflammatory mediators. Noteworthy, the multivalent and multispecific DARPin construct did not show any alteration of the beneficial biophysical properties of the monovalent parental DARPins. Hence, bispecific DARPins may be used to generate receptor antagonists simultaneously targeting different epitopes on the same molecule. Moreover, they easily overcome the limiting immunoglobulin binding paradigm (one binding molecule=one epitope) and thereby represent an alternative to monoclonal antibodies in cases where the immunoglobulin scaffold is unsuitable.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute for Immunology (discontinued)

UniBE Contributor:

Stadler, Beda Martin and Vogel, Monique

ISSN:

0022-2836

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:13

Last Modified:

06 Dec 2013 13:59

Publisher DOI:

10.1016/j.jmb.2009.08.014

PubMed ID:

19683003

Web of Science ID:

000271167400004

URI:

https://boris.unibe.ch/id/eprint/32344 (FactScience: 197445)

Actions (login required)

Edit item Edit item
Provide Feedback